Molecule fights cancer on two fronts
Researchers at the University of Leeds have made a new synthetic anti-cancer molecule that targets two key mechanisms in the spread of malignant tumours through the body.
Events News
Puree helps kids make smooth transition to vegetables
Adding tiny amounts of vegetable puree to milk and then rice at the time of weaning makes children more likely to eat vegetables, new University of Leeds research shows.
ESA's Rosetta mission - what is the comet lander looking for?
Today, the European Space Agency's (ESA) Rosetta mission is attempting one of the most ambitious manoeuvres in space exploration: to soft-land a robotic probe on a comet for the first time.
New plaque marks partnership to fight breast cancer
A plaque to mark a historic partnership between Breast Cancer Campaign and the University of Leeds, which is leading the fight against breast cancer, was unveiled in Leeds on Monday (November 10).
Woodland bat species sweats it out in the tropics
A bat species thought to be restricted to temperate forests has been found living thousands of miles from its known range in the sweltering heat of the southern Indian rainforest.
Researchers observe comet flyby effects on Martian atmosphere
A "once-in-a-lifetime" chance to watch a comet flying close to Mars gave a unique insight into the effect of such a near miss on a planet's atmosphere, according to a University of Leeds academic.
Increase in ozone destroying substances - but Montreal Protocol on track
Research from the University of Leeds and an international team of scientists has shown a recent increase in atmospheric hydrogen chloride (HCl), a substance linked to destruction of the ozone layer.
Scientists to debate the future of climate science and policy
The University of Leeds will host an event on Tuesday, 4 November to critically reflect on the key findings of a report on climate change that was recently published by a United Nations (UN) panel.
Sea sponge drug could boost advanced breast cancer survival by up to five months
The cancer drug eribulin, originally developed from sea sponges, could give women with advanced triple negative breast cancer an average of five extra months of life, new research says.
Researchers supported to take next career steps
Developing the next generation of researchers is the focus of a new £2m investment by the Wellcome Trust and the University of Leeds.